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Abstract
Rapid arterial O2 desaturation during apnea in the preterm infant has obvious clinical implications but to date no adequate
explanation for why it exists. Understanding the factors influencing the rate of arterial O2 desaturation during apnea (_ S SaO2)
is complicated by the non-linear O2 dissociation curve, falling pulmonary O2 uptake, and by the fact that O2 desaturation is
biphasic, exhibiting a rapid phase (stage 1) followed by a slower phase when severe desaturation develops (stage 2). Using a
mathematical model incorporating pulmonary uptake dynamics, we found that elevated metabolic O2 consumption
accelerates _ S SaO2 throughout the entire desaturation process. By contrast, the remaining factors have a restricted temporal
influence: low pre-apneic alveolar PO2 causes an early onset of desaturation, but thereafter has little impact; reduced lung
volume, hemoglobin content or cardiac output, accelerates _ S SaO2 during stage 1, and finally, total blood O2 capacity (blood
volume and hemoglobin content) alone determines _ S SaO2 during stage 2. Preterm infants with elevated metabolic rate,
respiratory depression, low lung volume, impaired cardiac reserve, anemia, or hypovolemia, are at risk for rapid and
profound apneic hypoxemia. Our insights provide a basic physiological framework that may guide clinical interpretation
and design of interventions for preventing sudden apneic hypoxemia.
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Introduction
Apnea and its accompanying arterial O2 desaturation are
common clinical complications in preterm infants, occurring in
more than 50% of very low birth weight infants [1]. In preterm
infants, apnea causes a reduction in heart rate [2] and cerebral
perfusion [3], often requires mechanical ventilation, and is
associated with neurodevelopmental impairment [4]. Apnea-
related hypoxemia is of major concern in light of evidence that
repetitive hypoxia in newborn animals results in irreversibly-
altered carotid body function [5], raising the possibility of
impaired ventilatory control, and causes neurocognitive and
behavioural deficits [6]. Respiratory arrest and hypoxemia are
also strongly implicated in sudden infant death syndrome (SIDS)
[7,8] where the speed at which hypoxemia develops is considered
to be particularly dangerous.
In preterm infants, the rate of arterial O2 desaturation (_ S SaO2)
can be highly variable and rapid, with average rates as high as
4.3% s
21 during isolated apneas [9]. An earlier framework to
describe _ S SaO2 proposed that metabolic O2 consumption relative to
alveolar volume determines the speed at which alveolar PO2 falls
[10]; it was envisaged that _ S SaO2 is then a function of falling PO2
and the slope of the oxy-hemoglobin dissociation curve. However,
such a model assumes that the rate of alveolar depletion of O2,
denoted pulmonary O2 uptake ( _ V VpO2), is equal to tissue O2
consumption during apnea (see Methods – Theory). Previous
studies in adults have shown that _ V VpO2 falls from metabolic
consumption during apnea [11], and our previous modeling
studies in lambs showed that the difference between _ V VpO2 and
metabolic O2 consumption has a crucial role in determining _ S SaO2
during recurrent apneas [12]. We found that apneic changes in
_ V VpO2 cause desaturation to occur in 2 stages. During stage 1, lung
O2 stores are depleted, and _ V VpO2 falls below metabolic
consumption. During stage 2, _ V VpO2 is close to zero, and tissue
O2 needs are provided by depletion of blood O2 stores.
To date, no complete theoretical analysis of the factors influencing
desaturation during apnea has been published. The only available
study [13] has a number of critical limitations. First, the model
incorporated a constraint of a fixed difference between SaO2 and
mixed-venous saturation; thus dynamic changes in _ V VpO2 could not
occur and their influence on _ S SaO2 could not be examined. Second, no
assessment was made of the impact of cardiorespiratory factors on the
two stages of O2 desaturation. Third, in focusing on adults, the study
did not examine profound desaturation to levels well below 60% as
can often occur in preterm infants [9,14].
Accordingly, the aim of the current study was to quantify the
importance of cardiorespiratory factors relevant to _ S SaO2 during
apnea, with particular reference to the preterm infant. Using a
model that permits variation of _ V VpO2 during apnea, we examine a
number of factors known to influence _ S SaO2, such as lung volume
[15], metabolic O2 consumption [16] and pre-apneic arterial
oxygenation [17] as well as factors that are particularly pertinent for
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O2 affinity, and chronically and acutely reduced cardiac output. We
use the results to develop a conceptual framework for the
interpretation of mechanisms underlying rapid _ S SaO2 during apnea.
Results
Overview of the two-compartment model for gas
exchange
To determine the independent influence of clinically relevant
cardiorespiratory factors on _ S SaO2 during a single isolated apnea,
we used a two-compartment lung-body mathematical model
which incorporated realistic blood O2 stores and gas exchange
dynamics (Figure 1), as described in Methods – Mathematical
model (a full list of symbols is provided in Table 1). We used
published parameters for healthy preterm infants born at ,30 wk
gestational age (Table 2); the values represent measurements taken
at approximately term equivalent age when surprisingly rapid
desaturation has been observed [9]. We also derive analytic
solutions for _ S SaO2 to quantify the importance of cardiorespiratory
factors on _ S SaO2 to obtain a detailed view of the arterial O2
desaturation process, as described in Methods – Theory.
Pulmonary gas exchange dynamics during apnea
To examine changes in O2/CO2 exchange during apnea, a
single apnea was imposed on the model. During apnea, changes in
alveolar O2 and CO2 stores are not constant (Figure 2);
importantly, alveolar PO2 (PAO2) did not continue to fall at its
initial rate as governed by metabolic O2 consumption ( _ V VO2), but
instead the rate of fall in PAO2 was reduced as it approached mixed
venous PO2 (P  v vO2), an observation also reflected in the falling
_ V VpO2. As a result, two distinct phases for O2 depletion can be seen,
which we refer to as stage 1 and stage 2 [12]. During stage 1, PAO2
fell rapidly and _ V VpO2 decreased and became dissociated from _ V VO2;
during stage 2, with _ V VpO2 greatly reduced, both PAO2 and P  v vO2 fell
together at a reduced rate. The two distinct phases were also
observed for alveolar and arterial PCO2 (PACO2, PaCO2) although
stage 1 for CO2 was substantially shorter than that for O2. Such an
effect results from the earlier fall in pulmonary CO2 uptake
( _ V VpCO2) relative to the fall in _ V VpO2 (Figure 2A) and is reflected in
the reduction in respiratory exchange ratio ( _ V VpCO2= _ V VpO2)
(Figure 2B). Consequently, a more rapid fall in PAO2 was observed
compared with the rise in PACO2(see Methods – Derivation of
equations), such that PAO2 fell by 100 mmHg in the time PACO2 rose
by just 14 mmHg (Figure 2C).
Time-course of _ S SaO2 during apnea
The time-course of _ S SaO2 is complex (Figure 3), a consequence of
the nonlinear O2-dissociation curve in combination with the fall in
_ V VpO2. At apnea onset, SaO2 started to fall with a rate equivalent to
that predicted by Equation 12, where _ S SaO2~0:5% s{1 (Figure 3).
During apnea, changes in the slope of the O2-dissociation curve
(bHbO2) and _ V VpO2 dominated the time-course of desaturation as
hypoxemia progressed. As SaO2 started to fall after apnea onset,
bHbO2 increased with little change in _ V VpO2, resulting in a
proportional increase in _ S SaO2. However, as arterial hypoxemia
developed, there was a concurrent decline in _ V VpO2.A s_ S SaO2 is
directly proportional to the product bHbO2| _ V VpO2 (Equation 11) it
follows that during apnea, the peak _ S SaO2 of 3.5% s
21 occurred
when bHbO2| _ V VpO2 reached a maximum. This occurred when
neither _ V VpO2 nor bHbO2 was at its maximum (both ,50% of peak).
Finally, with _ V VpO2 greatly reduced during stage 2, _ S SaO2 remained
at a constant level (_ S SaO2~1:7% s-1), close to that predicted by
Equation 13 (1.8% s
21).
Factors influencing _ S SaO2
The following parameters were individually varied from their
‘normal’ values to quantify their influence on _ S SaO2: resting PAO2,
Figure 1. Model schematic representing O2 uptake, transport
and consumption. O2 stores are represented by the alveolar, arterial,
and venous compartments. Two dynamically-independent levels of O2
uptake are denoted: pulmonary O2 uptake ( _ V VpO2) and metabolic
consumption ( _ V VO2). R-L shunt is also included. Ta is the arterial transit
time. Symbols are described in Table 1.
doi:10.1371/journal.pcbi.1000588.g001
Author Summary
When breathing stops, the flow of O2 into and the flow of
CO2 out of the body cease. Such an event, termed an
apnea, can be especially dangerous in preterm infants in
whom it can lead to a rapid decline in arterial O2
saturation, reaching rates of 3–8% per second, rapidly
reducing O2 to a level that could lead to neurological
damage. Despite extensive experimental research, we have
a poor mechanistic understanding of the causes of rapidly
developing hypoxemia. We describe a new mathematical
model that allows examination of the importance of the
major cardiorespiratory factors that are likely to influence
the speed at which arterial hypoxemia worsens during
apnea. We found that high metabolic rate as well as
reduced pre-apneic ventilation, lung volume, cardiac
output, hemoglobin content, blood O2 affinity, and blood
volume accelerate the development of hypoxemia during
apnea. Importantly, the cardiorespiratory factors that
contribute to rapid hypoxemia are all pertinent to the
preterm infant during early postnatal development. Thus
the newborn is highly susceptible to rapid and severe
desaturation, potentially explaining the propensity of
preterm infants, particularly those with apnea, to neuro-
logical impairment.
Factors Influencing Rapid Arterial O2 Desaturation
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hemoglobin content (Hb), cardiac output ( _ Q QT), R-L shunt fraction
(Fs), and the PO2 at 50% saturation (P50). All other parameters
were kept constant to remove confounding effects, unless specified
otherwise.
To quantify _ S SaO2 we used 3 different measures. First, since
apnea is considered clinically significant if it lasts for .10 s and is
accompanied by bradycardia or O2 desaturation [18], we
calculated the average rate of fall in SaO2 between apnea onset
and 10 s later (_ S Sa10 s
O2 ); such a measure describes the immediacy of
onset of desaturation and is analogous to the practical measure-
ment of average _ S SaO2 used in many clinical studies [9,15,19,20].
Second, we determined the peak instantaneous _ S SaO2 during apnea
Table 1. Mathematical symbols.
Symbol Description
CaCO2 Arterial CO2 content
CaO2 Arterial O2 content
Cc0
CO2 End-capillary arterial CO2 content
Cc0
O2 End-capillary arterial O2 content
C  v vCO2 Mixed venous CO2 content
C  v vO2 Mixed venous O2 content
_ C C  v vCO2 Rate of change in mixed venous CO2 content
_ C C  v vO2 Rate of change in mixed venous O2 content
FIO2 Fractional inspired O2
Fs R-L pulmonary shunt fraction ( _ Q Qp= _ Q QT)
Hb Hemoglobin content of blood
P0 Barometric pressure, including conversion from STP to BTP,
863 mmHg
P50 O2 partial pressure at 50% saturation
PO2 O2 partial pressure
PaCO2 Arterial CO2 partial pressure
PaO2 Arterial O2 partial pressure
PACO2 Alveolar CO2 partial pressure
PAN2 Alveolar N2 partial pressure
PAO2 Alveolar O2 partial pressure
Pvap Alveolar water vapour partial pressure, 47 mmHg
PB Barometric pressure, 760 mmHg
Pc0
CO2 End-capillary CO2 partial pressure
Pc0
O2 End-capillary O2 partial pressure
PICO2 Inspired CO2 partial pressure
PIN2 Inspired N2 partial pressure
PIO2 Inspired O2 partial pressure
P  v vO2 Mixed venous O2 partial pressure
P  v vCO2 Mixed venous CO2 partial pressure
_ P PACO2 Rate of change in alveolar CO2 partial pressure
_ P PAN2 Rate of change in alveolar N2 partial pressure
_ P PAO2 Rate of change in alveolar O2 partial pressure
Qa Arterial volume
Qb Blood volume
QbCO2 Blood volume for CO2
QbO2 Blood volume for O2
Qv Venous (and tissue) volume
QvCO2 Venous (and tissue) volume for CO2
QvO2 Venous (and tissue) volume for O2
_ Q QT Cardiac output
_ Q Qp Pulmonary blood flow
RER Respiratory exchange ratio ( _ V VpCO2= _ V VpO2)
SO2 O2 saturation
SaO2 Arterial O2 saturation
Sc0
O2 End-capillary arterial O2 saturation
S  v vO2 Mixed venous O2 saturation
_ S SaO2 Rate of arterial O2 desaturation
_ S Sa10 s
O2 Average _ S SaO2 from t=0–10 s during apnea
Symbol Description
_ S Sa
peak
O2 Peak instantaneous (‘linear’) _ S SaO2 during apnea; stage 1
_ S Sa
stage 2
O2
_ S SaO2 during stage 2
_ S S  v vO2 Rate of mixed-venous O2 desaturation
Ta Arterial transit time
VL Lung volume
_ V VCO2 Metabolic CO2 production
_ V VO2 Metabolic O2 consumption
_ V VE Expired alveolar ventilation
_ V VI Inspired alveolar ventilation
_ V VpCO2 Pulmonary CO2 uptake (from capillary to alveoli)
_ V VpO2 Pulmonary O2 uptake (from alveoli to capillary)
_ V Vptotal Net pulmonary gas uptake from alveoli to capillary
bbCO2 Capacitance co-efficient of blood for CO2
bbO2 Capacitance co-efficient of blood for O2 relating changes in
Pc0
O2 to changes in Cc0
O2
bHbO2 Capacitance co-efficient of hemoglobin for O2; slope of the O2-
dissociation curve relating changes in Pc0
O2 to changes in Sc0
O2
doi:10.1371/journal.pcbi.1000588.t001
Table 1. Cont.
Table 2. Typical parameters for the preterm infant at term
equivalent age.
Parameter Value Reference/s
Lung volume (VL) 20 ml kg
21 [31,54]
Metabolic O2 consumption ( _ V VO2) 10 ml min
21 kg
21 [55,39,40]
Cardiac output ( _ Q QT) 250 ml min
21 kg
21 [56]
Hemoglobin content (Hb) 8 g dl
21 [22]
P50 24 mmHg [22]
Blood volume (Qb) 80 ml kg
21 [57]
P50 is the partial pressure at 50% saturation. VL is taken from data on functional
residual capacity. For all simulations unless otherwise stated: respiratory exchange
ratio (RER) was assumed to be 0.8; shunt fraction (Fs) was adjusted to 8.7% to
achieve a resting PaO2 of 72 mmHg as is typical for normal healthy infants [58];
resting alveolar ventilation ( _ V VI~168 ml min-1kg-1 under normal conditions) was
set to achieve resting PAO2~100 mmHg.
doi:10.1371/journal.pcbi.1000588.t002
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peak
O2 ), the value during the linear portion of arterial desaturation
[10,21] which we find is not confounded by resting SaO2. Third,
we report a measure of SaO2 during stage 2 apnea (_ S Sa
stage 2
O2 ). To
quantify the sensitivity of _ S SaO2 to changes in each cardiorespira-
tory factor, we defined the term impact ratio as the ratio of
proportional increase in _ S SaO2 to a small increase from the normal
value of each factor. For example, an impact ratio of 1 indicates a
one-to-one increase in _ S SaO2 with an increase in the factor, and a
negative ratio indicates an inverse relationship. The impact of
each cardiorespiratory factor on _ S Sa10 s
O2 , _ S Sa
peak
O2 , and _ S Sa
stage 2
O2 is
summarised in Table 3.
Resting PAO2. Changes in PAO2, achieved via reduced resting
ventilation or increasing inspired O2 (FIO2), had a substantial effect
on the onset of desaturation. Reduced pre-apneic PAO2 dramatically
increased _ S Sa10 s
O2 (Figure 4A), but had little effect on _ S Sa
peak
O2 or
_ S Sa
stage 2
O2 . In contrast, increasing pre-apneic PAO2 with the
application of supplemental O2 achieved the opposite, essentially
right-shifting or delaying the arterial desaturation curve, where one
second of delay can be achieved by an increase in PIO2 (DPIO2)o f
,7 mmHg, or DFIO2 of ,1% (see Methods – Derivation of
equations). These results occurred despite only a minor influence
being visible on resting SaO2. For example, a reduction of PAO2 from
100 to 60 mmHg caused a 6% reduction in resting SaO2 but at the
same time led to a more than 2-fold elevation in _ S Sa10 s
O2 (Figure 4B).
Additionally, a severe reduction in PAO2, to below 70 mmHg, was
required to elevate _ S Sa
peak
O2 .
Lung volume (VL) and blood volume (Qb). _ S Sa10 s
O2 and
_ S Sa
peak
O2 were inversely related to VL during stage 1 (Figure 5A, B),
but changes in VL had no influence on _ S Sa
stage 2
O2 . In direct contrast,
reduced Qb strongly increased _ S Sa
stage 2
O2 , but had no effect on stage
Figure 2. Pulmonary gas exchange during apnea. (A) Rate of
pulmonary O2/CO2 exchange. _ V VpO2 and _ V VpCO2 fall from resting levels
during apnea. (B) Net alveolar-capillary gas uptake ( _ V Vptotal~ _ V VpO2{ _ V VpCO2)
and respiratory exchange ratio (RER~ _ V VpCO2= _ V VpO2)during apnea. (C)
Changes in alveolar, arterial and mixed venous PO2=PCO2 during apnea.
Contrast the time-course in PAO2 and PACO2 as they fall/rise towards
P  v vO2=P  v vCO2. (*) represents the fall in PAO2 if _ V VpO2 was assumed equal to
_ V VO2.S 1=s t a g e1 ;S 2=s t a g e2 .
doi:10.1371/journal.pcbi.1000588.g002
Figure 3. The time course of _ S SaO2 O2 during apnea. Panel (A) shows
the increase in the slope of the oxy-hemoglobin dissocation curve at
the level of alveolar PO2 (bHbO2), and the fall in pulmonary oxygen
uptake ( _ V VpO2) that occurs during apnea. Panel (B) shows that changes
in the product bHbO2| _ V VpO2 explain the time course of the instanta-
neous slope of arterial O2 desaturation (_ S SaO2) during apnea. Note that
the peak _ S SaO2 occurs when _ V VpO2 is substantially less than its resting
value. Note also that the rate of fall of mixed-venous saturation (_ S S  v vO2)
and _ S SaO2 become equal and constant after 20 s.
doi:10.1371/journal.pcbi.1000588.g003
Table 3. Impact ratios describing the effect of
cardiorespiratory factors on _ S SaO2.
Parameter alteration _ S Sa10 s
O2 O2
_ S Sa
peak
O2 O2
_ S Sa
stage 2
O2 O2
Resting PAO2 23.97 20.35 20.01
Lung volume (VL) 22.24 20.82 20.09
Blood volume (Qb) 20.01 20.06 20.68
O2 consumption ( _ V VO2)
CC +2.29 +1.00 +1.00
O2 consumption ( _ V VO2)
nCC +2.73 +1.92 +1.00
Hemoglobin content (Hb)
nCC 20.38 21.00 20.89
Hemoglobin content (Hb)
CC +0.01 20.10 20.89
P50 +1.37 20.68 20.11
Cardiac output ( _ Q QT, resting) 20.39 20.90 0.00
Cardiac output ( _ Q QT, transient) +1.45 20.06 0.00
Shunt Fraction (Fs) 20.01 +0.01 0.00
Impact ratio is defined as the ratio of proportional increase in _ S SaO2 to the
proportional increase in each factor, based on small changes around normal
values. An impact ratio of 1 indicates a one-to-one increase in _ S SaO2 >with an
increase in the factor, and a negative ratio indicates an inverse relationship.
CC=cardiac compensated, nCC=cardiac uncompensated.
doi:10.1371/journal.pcbi.1000588.t003
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peak
O2 or _ S Sa10 s
O2
(Figure 5C, D).
Metabolic O2 consumption ( _ V V O2). To examine the impact
of changing _ V VO2 on _ S SaO2, independent of resting S  v vO2, _ Q QT was
adjusted to maintain resting S  v vO2 constant, where
D _ Q QT(%)~D _ V VO2(%); we refer to this procedure as ‘cardiac
compensation’. Under this condition, elevated _ V VO2 caused a
directly proportional increase in SaO2 throughout stages 1 and 2
(Figure 6A, B). Without cardiac compensation, the effect of
increased _ V VO2 on SaO2 during stage 1 was magnified, as shown by
the further increase in _ S Sa
peak
O2 (Figure 6A, B).
Hemoglobin content (Hb) and oxygen affinity (P50). Re-
duced hemoglobin content (Hb) increased _ S Sa
peak
O2 and _ S Sa
stage 2
O2 but
had little effect on _ S Sa10 s
O2 (Figure 7A, B). The increase in _ S Sa
peak
O2
occurred with anincreaseinthe peakoftheproduct bHbO2| _ V VpO2 as
_ V VpO2 was higher at each level of SaO2. The simulation was repeated
with cardiac compensation for the reduction in hemoglobin content,
where D _ Q QT(%)~1=DHb(%), to maintain constant resting S  v vO2.
Following such compensation, no changes in _ S Sa
peak
O2 or _ S Sa10 s
O2 were
observed but reduced Hb continued to increase _ S Sa
stage 2
O2 .I n
examining the influence of P50,P 90 was adjusted in equal
proportion on the basis of published data [22]. Increased P50
increased the immediate _ S SaO2,i n c r e a s e d_ S Sa10 s
O2 ,d e c r e a s e d_ S Sa
peak
O2
and had no effect on _ S Sa
stage 2
O2 (Figure 7C, D).
Cardiac output ( _ Q QT). Reduced resting _ Q QT increased _ S Sa
peak
O2 ,
but had little impact on _ S Sa10 s
O2 or _ S Sa
stage 2
O2 (Figure 8A, B). As with
Hb, the increase in _ S Sa
peak
O2 with reduced resting _ Q QT occurred with
an increase in the peak of the product bHbO2| _ V VpO2.T o
differentiate between the influence on _ S SaO2 of an acute
reduction in cardiac output, i.e. when bradycardia accompanies
apnea, rather than a chronic reduction, we reduced cardiac output
in a step-wise manner from the baseline value at the time of apnea
onset. In constrast to the effect of reduced resting _ Q QT, a transient
reduction in _ Q QT decreased _ S Sa10 s
O2 , but had a negligible impact on
_ S Sa
peak
O2 or _ S Sa
stage 2
O2 (Figure 8C, D).
Resting R-L shunt fraction (Fs). Increased Fs reduced
resting SaO2 and S  v vO2 but had no effect on _ S Sa10 s
O2 , _ S Sa
peak
O2 ,o r
_ S Sa
stage 2
O2 (Figure 9A, B).
Discussion
Our model analysis of the rate of arterial O2 desaturation
during apnea demonstrates that pre-apneic ventilation, lung
volume, cardiac output, hemoglobin content and blood volume
exert unique effects on _ S SaO2 throughout the time-course of
desaturation, while metabolic O2 consumption is uniformly
influential throughout the process. Our analysis reveals that lung
volume and the slope of the O2-dissociation curve are important
early in the process, during what we refer to as stage 1 [12], but
not stage 2. For the first time, our study reveals that reduced
cardiac output and hemoglobin content, and as a consequence
resting mixed-venous saturation, substantially accelerate peak
_ S SaO2. Finally, low blood volume and hemoglobin content, and
therefore a low total blood O2 capacity, increase the speed of
desaturation, but only in stage 2. In addition to infants with
elevated metabolic needs and low lung volume, those with anemia,
cardiac dysfunction, or hypovolemia, which are common
complications of prematurity, are at heightened risk of rapid and
profound arterial desaturation during apnea.
Methodological considerations
To evaluate the independent effects of cardiorespiratory factors
on _ S SaO2 we used a two-compartment model, incorporating both
alveolar and blood gas stores. The inclusion of a realistic blood
store was crucial to reveal that changes in _ V VpO2 occur as a
consequence of arterial and mixed-venous saturation falling
Figure 4. Impact of pre-apneic alveolar PO2 O2 (ventilation, supplemental O2)o n_ S SaO2 O2. (A) Effect of three levels of alveolar PO2(PAO2), (i)
100 mmHg, (ii) 80 mmHg and (iii) 60 mmHg, on arterial (SaO2) and mixed venous (S  v vO2)O 2 desaturation during apnea. Note that arterial O2
desaturation is substantially right-shifted with increased PAO2. (B) Sensitivity of _ S SaO2 to changes in pre-apneic PAO2(FIO2). Note that reduced PAO2 has a
major impact on _ S Sa10 s
O2 but little impact on _ S Sa
stage 2
O2 ; the influence on _ S Sa
peak
O2 is small in the normal range but becomes stronger at low PAO2.
n=‘normal’ ’values; S1, stage 1 slope; S2, stage 2 slope.
doi:10.1371/journal.pcbi.1000588.g004
Factors Influencing Rapid Arterial O2 Desaturation
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to extend the previous framework based on the assumption of
constant _ V VpO2 [23], which prevented the recognition that a steep
O2-dissociation curve and low lung volume do not accelerate _ S SaO2
beyond stage 1. Furthermore, the varying _ V VpO2 permitted
recognition that cardiac output, hemoglobin content, and blood
volume have a major influence on _ S SaO2.
In the current study, the typical value of _ S SaO2 found using our
model was 3.5% s
21 whereas Poets and Southall [9] using beat-by-
beat oximetry in preterm infants reported a mean value for
_ S SaO2~4:3% s-1 during isolated apneas. Reasons for our lower
value may lie with our simplifying assumptions. Notably, we
assumed a homogenous lung compartment and complete gas
mixing and as such, the model incorporated neither limitation of
alveolar-capillary diffusion nor an uneven ventilation-perfusion
distribution, two factors that could cause an increase in _ S SaO2.I n
addition, we assumed a constant lung volume during apnea, equal
to published values of functional residual capacity, whereas it is
known that lung volume can fall during apnea [15,24]; based on
our data, a fall in lung volume to 15.5 ml min
21kg
21 immediately
after apnea onset would achieve _ S SaO2 of 4.3% s
21 (Figure 5B).
A final assumption implicit in our model is that all O2 transfer to
the blood occurs via the pulmonary circulation. However, in very
preterm infants there is evidence of percutaneous respiration in the
first few days of life in both room air and with supplemental O2
[25]. With whole body exposure of 90% O2 to the newborn skin, it
Figure 5. Impact of lung volume (VL) and blood volume (Qb) on _ S SaO2 O2. (A) Effect of three levels of VL, (i) 30, (ii) 20 and (iii) 10 ml kg
21,o n
arterial (SaO2) and mixed venous (S  v vO2)O 2 desaturation during apnea. (B) Sensitivity of _ S SaO2 to changes in VL. Note that reduced VL has a strong
impact on _ S Sa
peak
O2 and _ S Sa10 s
O2 but no impact on _ S Sa
stage 2
O2 . (C) Effect of three levels of Qb, (iv) 120, (v) 80 and (iv) 40 ml kg
21,o nSaO2 and S  v vO2 during
apnea. (D) Sensitivity of _ S SaO2 to changes in Qb. Note that reduced Qb has little impact on _ S Sa
peak
O2 or _ S Sa10 s
O2 but has a large impact on _ S Sa
stage 2
O2 .
n=‘normal’ values; S1, stage 1 slope; S2, stage 2 slope.
doi:10.1371/journal.pcbi.1000588.g005
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likely via an increased resting mixed-venous saturation; our study
demonstrates that such an effect would decrease _ S SaO2 during
apnea.
Pulmonary gas exchange dynamics during apnea
Our study is consistent with previous observations that _ V VpO2
and _ V VpCO2 rapidly decline during apnea from their steady-state
values [11], with _ V VpCO2 falling faster than _ V VpO2. The relatively
low blood capacitance for O2 compared with that for CO2 results
in the resting alveolar–mixed-venous partial pressure difference
being ,12-fold greater for O2 than for CO2. Consequently, when
apnea begins ,12 times more O2 than CO2 must diffuse across
the lung to obliterate the alveolar–mixed-venous partial pressure
difference. The slower fall in _ V VpO2 vs. _ V VpCO2 provides for a faster
depletion of alveolar O2 vs. CO2 stores; such an effect results in
complete desaturation of arterial blood in the time PaCO2 rises by
just 14 mmHg. These findings lead us to conclude that short-term
O2 homeostasis is more unstable than CO2 homeostasis and thus
that the danger of isolated apneas in infants is likely to be mediated
via hypoxemia rather than hypercapnia.
Factors influencing _ S SaO2
Our study provides for the first time a comprehensive analysis of
the factors that determine arterial desaturation during apnea in
preterm infants. We show that resting oxygenation in the form of
alveolar PO2 has the greatest influence on desaturation at apnea
onset. When apnea begins at an increasingly lower alveolar PO2,
_ S SaO2 more quickly reaches its maximum because PO2 rapidly
arrives at the steepest part of the O2-dissociation curve. This effect
explains the inverse relationship between mean _ S SaO2 and pre-
apneic SaO2 during apnea [17], but as we show the peak slope
itself is negligibly affected by reduced resting PO2 within the
normal range.
We demonstrate that _ S SaO2 is inversely related to lung volume
during stage 1 of apnea as a result of the greater reduction in
alveolar PO2 in poorly inflated lungs per unit of O2 transferred into
thepulmonarycapillaries.Thisanalysisisconsistent with the inverse
correlation between _ S SaO2 and lung volume [15], with the view that
active upper airway closure maintains lung volume and slows _ S SaO2
[27,28], and with our recent report that the application of
continuous positive airway pressure effectively slows _ S SaO2 in lambs
[29].However, oncestage 2 begins,thebloodbecomestheprincipal
source of O2 and thus the only store which influences _ S SaO2.
A novel finding from our study is that reduced resting mixed-
venous saturation, caused by either a reduced cardiac output or
reduced hemoglobin content, strongly elevates peak _ S SaO2,
independent of metabolic O2 consumption. We show that reduced
resting mixed-venous saturation accelerates _ S SaO2 via an increase in
the peak value of bHbO2| _ V VpO2; in other words, low mixed-venous
saturation provides for a greater pulmonary O2 uptake even in the
presence of a developing arterial hypoxemia, and thereby
increases _ S SaO2. A role for hemoglobin in determining _ S SaO2 is
consistent with the finding that elevated hemoglobin content in
adults slows _ S SaO2 during apnea [21]. In contrast, blood transfusion
to raise hemoglobin content in anemic preterm infants, a common
clinical therapy, has little or no impact on the severity of apneic
desaturation [30]. Our proposed explanation for the lack of benefit
of raising hemoglobin content via transfusion is that it also reduces
heart rate [30] and cardiac output. Thus, in the newborn, the rise
in mixed-venous saturation expected after transfusion is counter-
acted by a tendency for mixed-venous saturation to fall as a result
of reduced cardiac output. An investigation that failed to find an
effect of cardiac output on _ S SaO2 [23] did not account for our
Figure 6. Impact of metabolic O2 consumption ( _ V VO2 O2)o n_ S SaO2 O2. Panel (A) shows the effect of doubling _ V VO2 on arterial (SaO2) and mixed venous
(S  v vO2)O 2 during apnea; (i) 10 ml min
21kg
21, (ii) 20 ml min
21kg
21 with cardiac compensation (CC), and (iii) 20 ml min
21kg
21 with no CC (nCC). Note
that with CC, increased _ V VO2, from (i) to (ii), elevated _ S SaO2 uniformly at all levels of SaO2 during both stages 1 and 2; note that the level of SaO2 at the
inflection point (shown by short black lines) is unchanged. With nCC (iii), increased _ V VO2 caused a reduced resting S  v vO2 and lower SaO2 inflection, and
greater _ S SaO2 during stage 1, compared to (ii). (B) Sensitivity of _ S SaO2 to changes in _ V VO2. Note that with increased _ V VO2: a uniform increase in _ S Sa
peak
O2
occurred with CC, and a more-than-proportional increase was seen with nCC; _ S Sa10 s
O2 is elevated in both cases, but more so with nCC; a uniform
increase in _ S Sa
stage 2
O2 is shown regardless of CC. n=‘normal’ values; S1, stage 1 slope; S2, stage 2 slope.
doi:10.1371/journal.pcbi.1000588.g006
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have opposing influence on _ S SaO2. Importantly, we find that a
transient fall in cardiac output, characteristic of bradycardia
during apnea in preterm infants [2], conserves alveolar O2 via
reduced _ V VpO2 and thus reduces _ S SaO2 (see Equations 10 and 11).
Consistent with this finding, apneic bradycardia prevents a rapid
fall in SaO2 in adults [21].
We found that each of the factors examined exerts a unique and
therefore recognisable influence on the time course of the
desaturation process (Figure 10). Low alveolar PO2 can be
recognised by a left-shift of the desaturation trajectory so that
desaturation begins sooner following the onset of apnea. A steep
desaturation slope in the early phase of stage 1 points to a low
ratio of lung volume to metabolic O2 consumption. In the late
phase of stage 1, when desaturation proceeds in a linear fashion, a
low resting mixed-venous saturation accelerates _ S SaO2 and leaves
the fingerprint of a low inflection point in arterial O2 desaturation;
low resting mixed-venous saturation reflects low cardiac output or
hemoglobin content with respect to O2 consumption. Lastly rapid
_ S SaO2 during stage 2 signifies a low total blood O2 capacity with
respect to O2 consumption which would point to either low blood
volume or anemia. The presence of a constant R-L shunt, while
having no influence on _ S SaO2, causes a parallel downwards shift in
the desaturation trajectory. The unique impact of different factors
on the desaturation curve may be used to guide preventive clinical
intervention.
Figure 7. Impact of hemoglobin content (Hb) and O2 affinity (P50)o n_ S SaO2 O2. (A) Effect of three levels of Hb, (i) 12 g dl
21, (ii) 8 g dl
21 and (iii)
4gd l
21, on arterial (SaO2) and mixed venous (S  v vO2)O 2 desaturation during apnea. Note the fall in SaO2 at the inflection point (shown by short black
lines). Note also that the reduced Hb has little impact on desaturation above SaO2~80%. (B) Sensitivity of _ S SaO2 to changes in Hb. (C) Effect of three
levels of P50, (iv) 18 mmHg, (v) 24 mmHg, and (vi) 36 mmHg, on _ S SaO2. (D) Sensitivity of _ S SaO2 to changes in P50. n=‘normal’ values; S1, stage 1 slope;
S2, stage 2 slope.
doi:10.1371/journal.pcbi.1000588.g007
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We show theoretically that the lower lung volume [31] and
higher metabolic O2 consumption [32] of preterm compared to
term infants predisposes to a rapid onset and progression of
desaturation during apnea. Two reports offer support for this view.
First, rapid desaturation occurs in infants with low functional
residual capacity [15], a finding that may help to explain the more
frequent O2 desaturation events during active sleep [33] when
functional residual capacity is reduced. Second, frequent desatu-
ration is characteristic of preterm infants with bronchopulmonary
dysplasia (BPD) [34] whose O2 consumption is 25% greater [35],
and functional residual capacity is 25% less [36], than in preterm
infants without BPD; Equations 11 and 12 predict that such
differences increase both immediate and peak _ S SaO2 by ,70%. In
addition, hypoventilation and reduced resting PAO2 in infants with
BPD, as inferred from elevated PACO2 [37], further increase
desaturation at apnea onset. Our finding that each rise of 1% in
inspired O2 provides ,1 s of delay (right-shift) in the onset of
apneic desaturation (Equation 15) may guide the titration of
supplemental O2 for the prevention of apneic hypoxemia while
minimising the well known side-effects of long-term exposure to
hyperoxia.
Our study has implications for the management of infants in
clinical care. Metabolic O2 consumption can be elevated after
Figure 8. Impact of cardiac output ( _ Q QT)o n_ S SaO2 O2. (A) Effect of three levels of resting _ Q QT, (i) 375 ml min
21kg
21, (ii) 250 ml min
21kg
21, and (iii)
125 ml min
21kg
21, on arterial (SaO2) and mixed venous (S  v vO2)O 2 during apnea. Note that reduced _ Q QT elevates _ S SaO2, associated with a reduction in
resting S  v vO2 and reduction in SaO2 at the stage 1–2 transition or inflection point (shown by short black lines). (B) Sensitivity of _ S SaO2 to changes in _ Q QT.
Note the strong influence of _ Q QT on _ S Sa
peak
O2 , but negligible effect on _ S Sa10 s
O2 and _ S Sa
stage 2
O2 . (C) Simulations in (A) repeated for a step change in _ Q QT at apnea
onset by (iv) +125 ml min
21kg
21 (e.g. tachycardia), (v) 0 ml min
21kg
21, and (vi) 2125 ml min
21kg
21 (e.g. bradycardia), following resting
_ Q QT~250 ml min-1kg-1. Note that the transient effect of _ Q QT is opposite to the resting effect of _ Q QT on arterial desaturation during apnea. (D) Sensitivity
of _ S SaO2 to acute changes in _ Q QT during apnea. Note the strong influence of a step-change in _ Q QT on _ S Sa10 s
O2 , but negligible effect on _ S Sa
peak
O2 and _ S Sa
stage 2
O2 .
n=‘normal’ values.
doi:10.1371/journal.pcbi.1000588.g008
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adminstration of methylxanthines [40]. Despite the success of
methylxanthines in reducing the frequency of apnea and
bradycardia, such treatment has surprisingly little impact on
hypoxemic episodes [41]; we suggest that the elevated O2
consumption and the absence of bradycardia are likely to increase
_ S SaO2 during those apneas that persist despite treatment. The
severity of hypoxemic episodes is reduced by switching preterm
infants from supine to prone [42], which may increase functional
residual capacity [43] and improve diaphragm function, increase
tidal volume and increase resting alveolar PO2 [44]. Our finding
that low cardiac output leads to increased _ S SaO2 during apnea leads
to the suggestion that judicious adjustment of inotropic support in
infants with cardiac abnormalities could improve resting mixed-
venous saturation and reduce apneic hypoxemia.
Hypoxemic events become less frequent between infancy and
childhood, despite an unchanged apnea frequency [28], perhaps
as a result of a fall in O2 consumption per body weight. However,
before this occurs, infants experience a period of susceptibility to
rapid desaturation during apnea as a result of a fall in hemoglobin
content and O2 affinity [22] and a rise in O2 consumption [45].
The implications for SIDS are obvious in that these changes
coincide with the peak incidence for SIDS at 2–3 months [46].
SIDS also occurs disproportionately in preterm infants [46], who
manifest severe anemia [22] and greater O2 consumption. Infants
resuscitated from apparent life threatening events have been found
to have lower hemoglobin content [47], pointing to a potential role
for rapid _ S SaO2 in the progression of such events. It is possible that
the rapid development of apneic hypoxemia initiates prolonged
hypoxic cardiorespiratory depression that in turn leads to SIDS.
Conclusion
We have provided a mathematical framework for quantifying
the relative importance of key cardiorespiratory factors on the rate
of arterial O2 desaturation during apnea, with particular relevance
to preterm infants. For the first time we have demonstrated that
each of the factors examined has a signature influence on the
trajectory of desaturation, providing quantitative insight into the
causes of rapidly developing hypoxemia during apnea.
Figure 9. Impact of R-L shunt (Fs) on _ S SaO2 O2. (A) Effect of three levels of Fs, (i) 0%, (ii) 15%, and (iii) 30%, on arterial (SaO2) and mixed venous (S  v vO2)
O2 during apnea. Note that resting R-L shunt fraction has a negligible impact on _ S SaO2 during apnea. (B) Sensitivity of _ S SaO2 to changes in Fs.
n=‘normal’ values; S1, stage 1 slope; S2, stage 2 slope.
doi:10.1371/journal.pcbi.1000588.g009
Figure 10. Conceptual framework depicting the temporal
sequence of influence of the key cardiorespiratory factors on
_ S SaO2 O2. Note the regions of influence of lung volume (VL), cardiac output
( _ Q QT) and blood volume (Qb), each with respect to metabolic O2
consumption ( _ V VO2). Hemoglobin content (Hb) influences the latter
phase of stage 1 as well as stage 2. The impact of reduced VL is limited
to stage 1, and blood volume to stage 2. Reduced PAO2 causes a
leftward shift in the desaturation trajectory. Note that the point of
inflection at the transition between stages reveals the resting S  v vO2.
doi:10.1371/journal.pcbi.1000588.g010
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Mathematical model
Lung compartment. For the lung, a single homogeneous
compartment is assumed based on the model of Grodins et al [48].
Each equation describing changes in the alveolar partial pressure
of each gas (G) is based on the conservation of mass (specifically,
the pressure–volume product) and is expressed in terms of inspired
and expired alveolar ventilation and transfer of gases into the
pulmonary capillary:
_ P PAG~
_ V VIPIG{ _ V VEPAG{P0 _ V VpG
VL
ð1Þ
where _ P PAG represents the rate of change of alveolar PO2, PCO2, and
PN2; PIG represents the inspired alveolar partial pressure of each
gas G; P0 is atmospheric pressure converted from STP to BTP
(863 mmHg); _ V VpG represents _ V VpO2 and { _ V VpCO2, pulmonary gas
uptake (STPD) for O2 and CO2 ( _ V VpN2 was neglected in this study
for simplicity); _ V VI and _ V VE are inspired and expired alveolar
ventilation (BTPS). Accounting for the difference in _ V VE and _ V VI due
to a net pulmonary gas uptake into the pulmonary blood, yields:
_ V VE~ _ V VI{
P0
PB{Pvap
_ V Vptotal ð2Þ
where PB=barometric pressure (760 mmHg); Pvap =water
vapour pressure (47 mmHg); _ V Vptotal is the net pulmonary gas
uptake, _ V Vptotal~ _ V VpO2{ _ V VpCO2.
Since purely obstructive apneas are relatively rare in preterm infants
[49], an unobstructed airway was chosen as the standard model in this
study. In the current study it was assumed that lung volume did not fall
during apnea, as in active sleep [24], when apneic desaturation events
are most common [33]. With lung volume constant, conservation of
mass requires that passive airflow into the unobstructed airway must
occur in response to a net pulmonary gas uptake into the pulmonary
blood [11]. To account for this effect, we can write:
_ V VI~
P0
PB{Pvap
_ V Vptotal ð3Þ
Pilot simulations predicted that the volume of gas inflow during apnea
is unlikely to exceed physiological deadspace. Thus, during apnea PIG
is taken as PAG of the last exhaled breath prior to apnea onset.
For the current study we assumed diffusion equilibrium at the
pulmonary capillaries, such that PAG~Pc0
G. Gas uptake is
determined from the Fick equation; specifically, pulmonary blood
flow ( _ Q Qp), and the difference between end capillary (Cc0
G) and
mixed venous (C  v vG) content:
_ V VpG~ _ Q Qp(Cc0
G{C  v vG) ð4Þ
Utilising equations for R-L shunt, arterial content of each gas G is
determined from its end capillary (Cc0
G) and mixed venous (C  v vG)
content, and pulmonary shunt fraction (Fs):
CaG~(1{Fs)Cc0
Gz(Fs)C  v vG ð5Þ
Fs defines the ratio of pulmonary blood flow to cardiac output,
such that Fs=(1{ _ Q Qp)= _ Q QT.
Body compartment. Assuming that the PO2 of the venous
blood is equilibrated with the tissue PO2, the mass-balance
equations are:
_ C C  v vG~
_ Q QT CaG(t{Ta){C  v vG ½  { _ V VG
QvG
ð6Þ
where CaG(t{Ta) represents the gas content of O2 and CO2 in
the arterioles; Ta is arterial transit time; _ V VG represents _ V VO2 and
{ _ V VCO2, the metabolic consumption of O2 and production of
CO2; QvG represents QvO2 and QvCO2 the combined venous/
tissue volumes for O2 and CO2.
Blood O2 stores were partitioned by assigning blood volume
(Qb) to arterial (25%) and venous (75%) compartments [50] and
they were modelled assuming an entirely unmixed arterial
compartment, and an entirely mixed and homogenous venous
compartment. The arterial transit time (Ta) is constrained by the
arterial volume (Qa) by the relationship Ta~Qa= _ Q QT. The body
compartment volume QvO2 is taken as the venous volume. QvCO2,
the effective venous/tissue volume for CO2 is taken as the same
value for QvO2, based on published data (see Methods –
Derivation of equations). Physiologically this represents no
additional contribution of a specific tissue reservoir for CO2
within the time frame of apnea.
To characterise the O2-dissociation curve we used a modified
form of the equation of Severinghaus [51]. We re-expressed the
equation with respect to the partial pressure at 50% (P50) and at
90% (P90) saturation:
SO2~100½k2(PO2
3zk1PO2)
-1z1 
-1 ð7Þ
where k1~(9P50
3-P90
3)=(P90-9P50) and k2~P50
3zk1P50. Values
for P50 (24.0 mmHg) and P90 (53.6 mmHg), were obtained from
the data of Delivoria-Papadopoulos [22] for a 9–10 wk-old
preterm infant. O2 content (CO2,m lm l
21) includes that bound
to hemoglobin (Hb, g ml
21) and that dissolved in plasma:
CO2~1:36 Hb(SO2=100)z0:00003PO2 ð8Þ
The relationship between CO2 content (CCO2) and PCO2 was
assumed linear:
CCO2~bbCO2PCO2zkCO2 ð9Þ
where bbCO2~0:0048 ml ml
-1mmHg-1 and kCO2~0:364 ml ml
-1
as adapted for STPD from Grodins et al. [52].
Simulations were performed using software written in MA-
TLAB (The Mathworks; Natick, MA).
Theory
A general equation. In an earlier study we developed a
general relationship that describes the factors influencing the
magnitude of _ S SaO2 at any instant in time during apnea [12]:
_ S SaO2~
bbO2P0 _ Q QT
VL
(SaO2{S  v vO2) ð10Þ
where bbO2 is the capacitance co-efficient of blood for O2.T o
specifically demonstrate the role of gas exchange, it is more useful
to represent _ S SaO2 in terms of _ V VpO2. Using Equation 1 for O2
under conditions of apnea ( _ V VI, _ V VE~0), assuming PAO2~PaO2, and
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_ S SaO2~
bHbO2P0
VL
_ V VpO2 ð11Þ
where bHbO2 (% mmHg
21) is defined as the slope of the O2-
dissociation curve, specifically regarding end-capillary PO2 with
respect to SO2. It is clear from Equation 11 that _ S SaO2 is directly
proportional to the product bHbO2| _ V VpO2, which both vary
substantially during apneic arterial desaturation. Although
Equations 10 and 11 are useful conceptually, values for
(SaO2{S  v vO2)o r _ V VpO2 throughout apnea are unknown, and thus
_ S SaO2 is not simple to predict explicitly.
Special cases. The original framework to understand factors
influencing _ S SaO2 was based on the assumption that _ V VpO2~ _ V VO2
[10,23] which does not hold true during apnea [11,12]. However,
such an assumption is valid prior to any substantial fall in SaO2,
and as therefore useful to explicitly describe _ S SaO2 immediately
upon apnea onset (_ S Saonset
O2 ):
_ S Saonset
O2 ~
bHbO2P0
VL
_ V VO2 ð12Þ
Notably, Equation 12 demonstrates that for any level of _ V VO2 and
VL, _ S Saonset
O2 is intimately related to bHbO2. Consequently, _ S Saonset
O2
increases dramatically with reduced resting PAO2 (Figure 11).
Although no simple expression could be written to describe
_ S SaO2 explicitly for stage 1, we derived an expression for _ S SaO2
during stage 2 (see Methods – Derivation of equations), given by:
_ S Sa
stage 2
O2 ~
_ V VO2
1:36 Hb Qbz
VL
bHbO2P0
ð13Þ
Since the total blood O2 capacity (1:36 Hb Qb) is much greater
than VL=(bHbO2P0), _ S Sa
stage 2
O2 is determined principally by
(1:36 Hb Qb) with negligible influence coming from lung volume
(VL) and the slope of the O2-dissociation curve (bHbO2), as well as
_ Q QT. Using the values for the preterm infant in Table 2 and
maximum bHbO2~2:8% mmHg-1, Equation 13 predicts that
_ S Sa
stage 2
O2 ~1:8% s-1. The little remaining _ V VpO2 during stage 2
can be found by combining Equations 11 and 13:
_ V VpO2~
VL=(bHbO2P0)
1:36 Hb QbzVL=(bHbO2P0)
_ V VO2 ð14Þ
Equation 14 predicts that _ V VpO2~8:5% of its resting value during
stage 2. Notably, _ V VpO2 is increased by reducing Hb and Qb; the
greater _ V VpO2 and thus a greater rate of alveolar O2 depletion with
reduced blood O2 capacity (1:36 Hb Qb) will increase _ S Sa
stage 2
O2 .
How can we reconcile that Equation 13 shows that VL no
longer influences _ S SaO2 during stage 2, when the general equation
(Equation 11) implies that reduced VL will accelerate _ S SaO2
throughout apneic desaturation? Equation 14 reveals that during
stage 2, elevated VL also acts to increase _ V VpO2; thus nearly entirely
offsetting the direct influence on _ S SaO2. The same applies for
reduced bHbO2, which acts to elevate _ V VpO2 and therefore no longer
accelerates _ S SaO2 during stage 2.
Derivation of equations
Here we derive the explicit equations used within the current
study to encapsulate key relationships pertaining to gas exchange
and arterial desaturation during apnea.
Stage 2 arterial O2 desaturation.. This section details the
derivation of an explicit equation to predict the rate of both
arterial and venous desaturation during the severe desaturation of
stage 2, a phase where _ V VpO2 is substantially reduced below _ V VO2
and both SaO2 and S  v vO2 fall at the same rate. Ignoring dissolved
plasma O2, consideration of Equation 1 for O2 and assuming
_ S SaO2~_ S S  v vO2 yields:
_ S SaO2~
_ V VO2{1:36 Hb _ Q QT SaO2(t{Ta){S  v vO2 ðÞ
1:36 Hb Qv
ð15Þ
By substituting the following relationships into Equation 15:
SaO2(t-Ta)-S  v vO2 ðÞ ~(SaO2-S  v vO2)z_ S SaO2Ta; Ta~Qa= _ Q QT;Q b =
Qa+Qv; _ V VpO2~1:36 Hb _ Q QT(SaO2-S  v vO2); it can be shown that
_ S SaO2 is directly proportional to the difference between _ V VO2 and
_ V VpO2, where:
_ S SaO2~
_ V VO2{ _ V VpO2
1:36 Hb Qb
ð16Þ
Combining Equations 11 and 16 yields Equation 13.
Estimation of effective blood volume for CO2. Using the
same methodology as described above, the ratio of _ C C  v vO2 to _ C C  v vCO2
during stage 2 can be used to estimate the ratio of QbCO2 to QbO2.
_ C C  v vO2 and _ C C  v vCO2 can be found using:
_ C CaG~ _ C C  v vG~{
_ V VG
QbGz
VL
bbGP0
ð17Þ
where QbO2 and QbCO2 are the effective blood volumes for O2/
Figure 11. Relationship between the slope of the oxy-
hemoglobin dissociation curve and alveolar PO2 O2. Note that
reduced alveolar PO2 (PAO2) causes a substantial increase in the slope of
the oxy-hemoglobin dissociation curve (bHbO2; see inset) and in _ S SaO2 at
apnea onset (_ S Saonset
O2 ; based on Equation 12).
doi:10.1371/journal.pcbi.1000588.g011
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pulmonary gas exchange, combining Equation 17 for O2 and CO2
gives:
QbCO2
QbO2
~{
_ C C  v vO2
_ C C  v vCO2
_ V VCO2
_ V V O2
ð18Þ
Equation 18 permitted the calculation of QvCO2=QvO2 based on
published data [53; their Figure 3] where during apnea the rate of
rise in C  v vCO2 is very close to the rate of fall in the product of C  v vO2
and the respiratory exchange ratio (RER); using
{ _ C C  v vO2= _ C C  v vCO2~1:29 from their data, and assuming resting
RER=0.8, we find that QbCO2=QbO2~1:03 or approximately 1.
Thus QvCO2=QvO2 is assumed to be 1.
Stage 1 hypercapnia. Here we develop a relationship to
describe the time-course of alveolar/arterial hypercapnia during
stage 1 for CO2. Using Equation 1 for CO2, taking _ V VI, _ V VE~0,
gives the relationship _ P PACO2~P0 _ V VpCO2=VL. Substituting the
steady-state Fick equation, _ V VpCO2~bbCO2 _ Q QT(PaCO2-P  v vCO2),
assuming alveolar-arterial equilibrium (PaCO2~PACO2), using
_ V VpCO2~ _ V VCO2 under resting conditions, assuming that P  v vCO2 is
constant, and solving for PACO2 yields:
PACO2~P  v vCO2{
_ V VCO2
bbCO2 _ Q QT
e{
bbCO2
P0
_ Q QT
VL t ð19Þ
Calculating the rate of rise in PACO2 (_ P PACO2) by taking the derivative
gives:
_ P PACO2~
P0 _ V VCO2
VL
e{
bbCO2
P0
_ Q QT
VL t ð20Þ
Equations 19 and 20 describe the slowing of _ P PACO2 from the
initial rate _ P PACO2~P0 _ V VpCO2=VL as PACO2 rises towards P  v vCO2.
Specifically, the time constant t~VL=(bbCO2P0 _ Q QT) demonstrates
that high bbCO2 causes a rapid slowing of _ V VpCO2 and hence of
_ P PACO2 as the arterial value approaches venous value. Indeed, fitting
an exponential curve to the PACO2 trace (Figure 2) during the first
5 s of apnea yielded a rapid time constant of 1.26 s, a value close
to that predicted by VL=(bbCO2P0 _ Q QT). The corollary is that the
low value of bbO2 prevents the slowing of _ V VpO2 as desaturation
progresses, giving rise to a rapid PAO2 decline and thus rapid
arterial desaturation. Likewise, further reducing bbO2 by lowering
hemoglobin content potentiates such effect.
Impact of supplemental O2. The delay (right-shift) in
arterial desaturation during apnea with increasing supplemental
O2 (DPIO2) can be predicted explicitly. Using Equation 1 for O2
under the conditions of apnea, and assuming DPIO2~DPAO2, the
delay (Dt) in arterial desaturation is given by:
Dt~
DPIO2VL
P0 _ V VO2
ð21Þ
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